Table 1.
Patients characteristics in early ovarian cancer (n = 71)
| Characteristics | Total |
|---|---|
| Age (year) at time of operation |
|
| Median (range) |
46 (22–65) |
| Body weight (kg) |
55.6 (42–78) |
| Height (cm) |
158 (144–165) |
| Body mass index |
23 (15.6-34.6) |
| Type of disease, n (%) |
|
| Ovarian cancer |
69 (97.2%) |
| Tubal cancer |
2 (2.8%) |
| Stage (FIGO, 1989), n (%) |
|
| Ia |
25 (35.2%) |
| Ib |
1 (1.4%) |
| Ic |
26 (36.6%) |
| IIa |
1 (1.4%) |
| IIb |
10 (14.1%) |
| IIc |
8 (11.3%) |
| Histology, n (%) |
|
| Serous |
15 (21.1%) |
| Mucinous |
11 (15.5%) |
| Endometrioid |
14 (19.7%) |
| Clear cell |
15 (21.1%) |
| Transitional cell |
3 (4.2%) |
| Others including mixed |
13 (18.3%) |
| CA125 (U/mL)* |
|
| Median (range) |
42 (1.9–4389) |
| ≥35, n (%) |
39 (57.4%) |
| LN dissection, n (%) |
69 (97.2%) |
| Number of LN dissected |
|
| Median (range) |
22 (3–98) |
| Chemotherapy | 61 (85.9%) |
FIGO, International Federation of Gynecology and Obstetrics; LN, lymph node.
*CA125 was available in 68 women.